
APGE vs JPIE
$APGE vs $JPIE head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
APGE vs JPIE: the quick read
- ·APGE is the larger company by market cap ($10.18B vs $10.05B).
- ·JPIE has been more active on our scanner (2 vs 0 alerts in 30 days).
- ·These sit in different industries (BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) vs UNKNOWN), so they answer to different catalysts and a move in one says little about the other.
- ·They are closely matched in size, within 1% of each other on market cap, which makes the rest of this table the interesting part.
- ·Both sit in the bottom quarter of their 52-week range, so this is a comparison of two names well off their highs.
- ·JPIE pays a dividend and APGE does not, which usually means one is being held for income and the other for the move.
- ·They are pulling apart today: JPIE is outperforming the other by roughly 100.0 percentage points on the session.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing APGE and JPIE on TheDesperateTrader.
- Is APGE or JPIE the better stock?
- "Better" depends on your goal, and these two are not alike. APGE is the larger company by market cap ($10.18B vs $10.05B). JPIE has been more active on our scanner (2 vs 0 alerts in 30 days). These sit in different industries (BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) vs UNKNOWN), so they answer to different catalysts and a move in one says little about the other. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between APGE and JPIE?
- The differences that matter: they are not in the same business - APGE is biological products, (no diagnostic substances) and JPIE is unknown; they are similar in size ($10.18B vs $10.05B); APGE sits at -38% of its 52-week range against 5% for JPIE; only JPIE pays a dividend; our scanner flagged APGE 0 times in the last 30 days against 2 for JPIE. Everything above is measured from the latest completed session and SEC filings.
- Which of APGE and JPIE is more active right now?
- Neither is showing unusual volume on the latest session, so nothing here is being driven by a volume spike. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading APGE or JPIE? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysExplore the market
Free, live market tools. No account required to look.